Skip to main content

Advertisement

SpringerLink
Log in

Incidence, Survival and Prognostic Factors of Oesophagogastric Cancer

  • Original Research
  • Published:
Journal of Gastrointestinal Cancer Aims and scope Submit manuscript

Abstract

Introduction

Oesophagogastric cancer is one of the leading causes of cancer death worldwide due to its aggressive nature. Despite the high mortality rate, there is limited information regarding this cancer in Brunei.

Aim

To estimate the incidence and survival duration of oesophagogastric cancer patients, to identify prognostic factors of oesophagogastric cancer and associated factors for late-stage oesophagogastric cancer detection.

Methods

A retrospective study on all oesophagogastric cancer patients registered in the population-based national cancer registry in Brunei from January 2010 to December 2018. Kaplan-Meier and Cox proportional hazard regression survival analyses and multiple logistic regression were applied.

Results

Sixty-eight oesophagogastric cancer patients’ data were retrieved from the registry. The incidence was 2.75 cases per 100,000 adults per year. Median survival time was 1.18 years (95% CI: 0.77, 1.80) and the 3-year survival rate was 26.3%. Age (61–70 years) (adjusted HR = 0.38; 95% CI: 0.17, 0.89; p = 0.025) and those who have undergone chemotherapy (adj. HR = 0.40; 95% CI: 0.18, 0.90; p = 0.026) have a significantly lower mortality risk. Obesity (adj. HR = 11.94; 95% CI: 1.94, 73.36; p = 0.007), and stage 4 (advanced stage) cancer (adj. HR=4.11; 95% CI: 1.97, 8.58; p< 0.001) have a significantly higher mortality risk. Females have 3-time odds (adj. OR = 3.05; 95% CI: 1.09, 9.02; p = 0.038) of presenting with stage 4 cancer. Smokers have 13-time odds (Adj. OR=12.99; 95% CI: 1.92, 262.0; p = 0.025) of presenting with stage 4 cancer.

Conclusion

Prognosis of oesophagogastric cancer remains poor. Addressing late detection and improve endoscopic surveillance and awareness of symptoms may help improve prognosis and mortality.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Zali H, Rezaei-Tavirani M, Azodi M. Gastric cancer: prevention, risk factors and treatment. Gastroenterol Hepatol Bed Bench. 2011;4(4):175–85.

    PubMed  PubMed Central  Google Scholar 

  2. World Health Organization. Latest global cancer data: Cancer burden rises to 18.1 million new cases and 9.6 million cancer deaths in 2018. Int Agency Res Cancer. 2018;(September):13–5. [Internet]. Available from: https://www.iarc.fr/wp-content/uploads/2018/09/pr263_E.pdf. [Cited 2020 Aug 2].

  3. Maron SB, Catenacci DVT. Novel targeted therapies for esophagogastric cancer. Surg Oncol Clin N Am. 2017;26(2):293–312.

    PubMed  PubMed Central  Google Scholar 

  4. Lambert R, Hainaut P. The multidisciplinary management of gastrointestinal cancer. Epidemiology of oesophagogastric cancer. Best Pract Res Clin Gastroenterol. 2007;21(6):921–45 [Internet]. [cited 2020 Aug 1]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18070696.

    CAS  PubMed  Google Scholar 

  5. Sehdev A, Catenacci DV. Gastroesophageal cancer: focus on epidemiology, classification, and staging. Discovery medicine. 2013;16(87):103–11.

  6. Huang F-L, Yu S-J. Esophageal cancer: risk factors, genetic association, and treatment. Asian J Surg. 2018;41(3):210–5 [Internet]. [cited 2020 Jul 29]. Available from: https://www.sciencedirect.com/science/article/pii/S1015958416302019.

    PubMed  Google Scholar 

  7. Stapley S, Peters TJ, Neal RD, Rose PW, Walter FM, Hamilton W. The risk of oesophago-gastric cancer in symptomatic patients in primary care: a large case–control study using electronic records. Br J Cancer. 2013;108(1):25–31 [Internet]. [cited 2020 Jul 30]. Available from: http://www.nature.com/articles/bjc2012551.

    CAS  PubMed  Google Scholar 

  8. Asadi-Lari M, Homaee-Shandiz F, Esmaeili-Hesari A. Changes in health-related quality of life in oesophagogastric cancer patients participating in palliative and curative therapies. Med J Islam Repub Iran. 2018;32:31.

    PubMed  PubMed Central  Google Scholar 

  9. Ministry of Health. Health Information Booklet 2017. 2017;1–72. [Internet]. [Cited 2020 Aug 1]. Available from: http://www.moh.gov.bn/Downloadables/Health%20Information%20Bookler%202017%20(revised%20as%20of%20January%202019).pdf.

  10. Wong MCS, Hamilton W, Whiteman DC, Jiang JY, Qiao Y, Fung FDH, et al. Global Incidence and mortality of oesophageal cancer and their correlation with socioeconomic indicators temporal patterns and trends in 41 countries. Sci Rep. 2018;8(1):4522 [Internet]. [cited 2020 Aug 1]. Available from: http://www.nature.com/articles/s41598-018-19819-8.

    PubMed  PubMed Central  Google Scholar 

  11. GBD 2017 Stomach Cancer Collaborators A, Safiri S, Sepanlou SG, Ikuta K, Bisignano C, Shakeri R, et al. The global, regional, and national burden of stomach cancer in 195 countries, 1990-2017: a systematic analysis for the Global Burden of Disease study 2017. Lancet Gastroenterol Hepatol. 2020;5(1):42–54 [Internet]. [cited 2020 Aug 2]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/31648970.

    Google Scholar 

  12. Sitarz R, Skierucha M, Mielko J, Offerhaus GJA, Maciejewski R, Polkowski WP. Gastric cancer: epidemiology, prevention, classification, and treatment. Cancer Manag Res. 2018;10:239–48 [Internet]. [cited 2020 Aug 1]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29445300.

    CAS  PubMed  PubMed Central  Google Scholar 

  13. Buckland G, Travier N, Huerta JM, Bueno-de-Mesquita HBA, Siersema PD, Skeie G, et al. Healthy lifestyle index and risk of gastric adenocarcinoma in the EPIC cohort study. Int J Cancer. 2015;137(3):598–606 [Internet]. [cited 2020 Aug 2]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25557932.

    CAS  PubMed  Google Scholar 

  14. Dehdari T, Dehdari L, Jazayeri S. Diet-related stomach cancer behavior among Iranian college students: a text messaging intervention. Asian Pac J Cancer Prev. 2016;17(12):5165–72 [Internet]. [cited 2020 Aug 1]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28124882.

    PubMed  PubMed Central  Google Scholar 

  15. Kunzmann AT, Mallon KP, Hunter RF, Cardwell CR, McMenamin ÚC, Spence AD, et al. Physical activity, sedentary behaviour and risk of oesophago-gastric cancer: a prospective cohort study within UK Biobank. United European Gastroenterol J. 2018;6(8):1144–54 [Internet]. [cited 2020 Aug 3]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30288276.

    PubMed  PubMed Central  Google Scholar 

  16. Tang L, Lee AH, Xu F, Zhang T, Lei J, Binns CW. Fruit and vegetable consumption and risk of esophageal cancer: a case-control study in north-west China. Dis Esophagus. 2014;27(8):777–82 [Internet]. [cited 2020 Aug 3]. Available from: https://academic.oup.com/dote/article-lookup/doi/10.1111/dote.12157.

    CAS  PubMed  Google Scholar 

  17. Larsson SC, Bergkvist L, Wolk A. Fruit and vegetable consumption and incidence of gastric cancer: a prospective study. Cancer Epidemiol Biomark Prev. 2006;15(10):1998–2001 [Internet]. [cited 2020 Aug 3]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17035412.

    Google Scholar 

  18. Gonzalez CA, Lujan-Barroso L, Bueno-de-Mesquita HB, Jenab M, Duell EJ, Agudo A, et al. Fruit and vegetable intake and the risk of gastric adenocarcinoma: A reanalysis of the european prospective investigation into cancer and nutrition (EPIC-EURGAST) study after a longer follow-up. Int J Cancer. 2012;131(12):2910–9 [Internet]. [cited 2020 Aug 3]. Available from. https://doi.org/10.1002/ijc.27565.

    Article  CAS  PubMed  Google Scholar 

  19. Xie S-H, Lagergren J. The male predominance in esophageal adenocarcinoma. Clin Gastroenterol Hepatol. 2016;14(3):338–347.e1 [Internet]. [cited 2020 Aug 3]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26484704.

    PubMed  Google Scholar 

  20. Mathieu LN, Kanarek NF, Tsai H-L, Rudin CM, Brock MV. Age and sex differences in the incidence of esophageal adenocarcinoma: results from the Surveillance, Epidemiology, and End Results (SEER) Registry (1973-2008). Dis Esophagus. 2014;27(8):757–63 [Internet]. [cited 2020 Aug 3]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24118313.

    CAS  PubMed  Google Scholar 

  21. Wroblewski LE, Peek RM, Wilson KT, Wilson KT. Helicobacter pylori and gastric cancer: factors that modulate disease risk. Clin Microbiol Rev. 2010;23(4):713–39 [Internet]. [cited 2020 Aug 3]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20930071.

    CAS  PubMed  PubMed Central  Google Scholar 

  22. Ishaq S, Nunn L. Helicobacter pylori and gastric cancer: a state of the art review. Gastroenterol Hepatol Bed Bench. 2015;8(Suppl 1):S6–14 [Internet]. [cited 2020 Aug 3]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26171139.

    PubMed  PubMed Central  Google Scholar 

  23. Uno Y. Prevention of gastric cancer by Helicobacter pylori eradication: a review from Japan. Cancer Med. 2019;8(8):cam4.2277 [Internet]. [cited 2020 Aug 3]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/31119891.

    Google Scholar 

  24. Zaridze DG, Basieva T, Kabulov M, Day NE, Duffy SW. Oesophageal cancer in the Republic of Karakalpakstan. Int J Epidemiol. 1992;21(4):643–8 [Internet]. [cited 2020 Aug 3]. Available from. https://doi.org/10.1093/ije/21.4.643.

    Article  CAS  PubMed  Google Scholar 

  25. Lui FH, Tuan B, Swenson SL, Wong RJ. Ethnic disparities in gastric cancer incidence and survival in the USA: an updated analysis of 1992–2009 SEER data. Dig Dis Sci. 2014;59(12):3027–34 [Internet]. [cited 2020 Aug 2]. Available from. https://doi.org/10.1007/s10620-014-3275-3.

    Article  PubMed  Google Scholar 

  26. Coupland VH, Lagergren J, Konfortion J, Allum W, Mendall MA, Hardwick RH, et al. Ethnicity in relation to incidence of oesophageal and gastric cancer in England. Br J Cancer. 2012;107(11):1908–14 [Internet]. [cited 2020 Aug 3]. Available from: http://www.nature.com/articles/bjc2012465.

    CAS  PubMed  PubMed Central  Google Scholar 

  27. Chen S, Zhou K, Yang L, Ding G, Li H. Racial differences in esophageal squamous cell carcinoma: incidence and molecular features. Biomed Res Int. 2017;2017:1204082 [Internet]. [cited 2020 Aug 3]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28393072.

    PubMed  PubMed Central  Google Scholar 

  28. Cook MB, Chow W-H, Devesa SS. Oesophageal cancer incidence in the United States by race, sex, and histologic type, 1977–2005. Br J Cancer. 2009;101(5):855–9 [Internet]. [cited 2020 Aug 3]. Available from: http://www.nature.com/articles/6605246.

    CAS  PubMed  PubMed Central  Google Scholar 

  29. Shikata K, Kiyohara Y, Kubo M, Yonemoto K, Ninomiya T, Shirota T, et al. A prospective study of dietary salt intake and gastric cancer incidence in a defined Japanese population: The Hisayama study. Int J Cancer. 2006;119(1):196–201 [Internet]. [cited 2020 Aug 3]. Available from. https://doi.org/10.1002/ijc.21822.

    Article  CAS  PubMed  Google Scholar 

  30. Sekikawa A, Fukui H, Maruo T, Tsumura T, Okabe Y, Osaki Y. Diabetes mellitus increases the risk of early gastric cancer development. Eur J Cancer. 2014;50(12):2065–71 [Internet]. [cited 2020 Aug 3]. Available from: https://www.sciencedirect.com/science/article/abs/pii/S0959804914007199.

    PubMed  Google Scholar 

  31. Cheung KS, Chan EW, Chen L, Seto WK, Wong ICK, Leung WK. Diabetes increases risk of gastric cancer after helicobacter pylori eradication: a territory-wide study with propensity score analysis. Diabetes Care. 2019;42(9):1769–75 [Internet]. [cited 2020 Aug 3]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/31296646.

    CAS  PubMed  Google Scholar 

  32. Morimoto N, Nagai M, Ohta Y, Miyazaki K, Kurata T, Morimoto M, et al. Increased autophagy in transgenic mice with a G93A mutant SOD1 gene. Brain Res. 2007;1167:112–7.

    CAS  PubMed  Google Scholar 

  33. Yang H-J, Kang D, Chang Y, Ahn J, Ryu S, Cho J, et al. Diabetes mellitus is associated with an increased risk of gastric cancer: a cohort study. Gastric Cancer. 2020;23(3):382–90 [Internet]. [cited 2020 Aug 3]. Available from. https://doi.org/10.1007/s10120-019-01033-8.

    Article  CAS  PubMed  Google Scholar 

  34. Xu B, Zhou X, Li X, Liu C, Yang C. Diabetes mellitus carries a risk of esophageal cancer: a meta-analysis. Medicine (Baltimore). 2017;96(35):e7944 [Internet]. [cited 2020 Aug 3]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28858123.

    Google Scholar 

  35. Rust P, Ekmekcioglu C. Impact of salt intake on the pathogenesis and treatment of hypertension. Adv Exp Med Biol. 2017;956:61–84 [Internet]. [cited 2020 Aug 3]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27757935.

    PubMed  Google Scholar 

  36. Cappuccio FP. Cardiovascular and other effects of salt consumption. Kidney Int Suppl. 2013;3(4):312–5 [Internet]. [cited 2020 Aug 3]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25019010.

    CAS  Google Scholar 

  37. Nagai M, Hashimoto T, Yanagawa H, Yokoyama H, Minowa M. Relationship of diet to the incidence of esophageal and stomach cancer in Japan. Nutr Cancer. 1982;3(4):257–68 [Internet]. [cited 2020 Aug 3]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/6890672.

    CAS  PubMed  Google Scholar 

  38. He FJ, MacGregor GA. A comprehensive review on salt and health and current experience of worldwide salt reduction programmes. J Hum Hypertens. 2009;23(6):363–84 [Internet]. [cited 2020 Aug 3]. Available from: http://www.nature.com/articles/jhh2008144.

    CAS  PubMed  Google Scholar 

  39. American Heart Association. Prevention and treatment of high cholesterol (hyperlipidemia). 2017. [Internet]. [Cited 2020 Aug 3]. Available from: https://www.heart.org/en/health-topics/cholesterol/prevention-andtreatment-of-high-cholesterol-hyperlipidemia.

  40. Ding X, Zhang W, Li S, Yang H. The role of cholesterol metabolism in cancer. Am J Cancer Res. 2019;9(2):219 [Internet]. [cited 2020 Aug 3]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405981/.

    CAS  PubMed  PubMed Central  Google Scholar 

  41. Shen Y, Wang C, Ren Y, Ye J. A comprehensive look at the role of hyperlipidemia in promoting colorectal cancer liver metastasis. J Cancer. 2018;9(16):2981–6 [Internet]. [cited 2020 Aug 3]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30123367.

    PubMed  PubMed Central  Google Scholar 

  42. Mehlen P, Puisieux A. Metastasis: a question of life or death. Nat Rev Cancer. 2006;6(6):449–58 [Internet]. [cited 2020 Aug 3]. Available from: http://www.nature.com/articles/nrc1886.

    CAS  PubMed  Google Scholar 

  43. Bashash M, Shah A, Hislop G, Brooks-Wilson A, Le N, Bajdik C. Incidence and survival for gastric and esophageal cancer diagnosed in British Columbia, 1990 to 1999. Can J Gastroenterol. 2008;22:143–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  44. Pennathur A, Gibson MK, Jobe BA, Luketich JD. Oesophageal carcinoma. Lancet. 2013;381:400–12.

    Google Scholar 

  45. Macmillan Cancer Support. A research briefing paper by Macmillan Cancer Support. 2012. [Internet]. [Cited 2020 Aug 1]. Available from: https://www.macmillan.org.uk/_images/living-after-cancer-median-cancersurvival-times_tcm9-283683.pdf.

  46. Crane SJ, Locke GR, Harmsen WS, Zinsmeister AR, Romero Y, Talley NJ, et al. Survival trends in patients with gastric and esophageal adenocarcinomas: a population-based study. Mayo Clin Proc. 2008;83(10):1087–94 [Internet]. [cited 2020 Aug 3]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18828967.

    PubMed  Google Scholar 

  47. Hua Z, Zheng X, Xue H, Wang J, Yao J. Long-term trends and survival analysis of esophageal and gastric cancer in Yangzhong, 1991-2013. PLoS One. 2017;12(3):e0173896.

  48. Veisani Y, Delpisheh A, Sayehmiri K, Rahimi E. Demographic and histological predictors of survival in patients with gastric and esophageal carcinoma. Iran Red Crescent Med J. 2013;15(7):547–53 [Internet]. [cited 2020 Aug 3]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24396572.

    PubMed  PubMed Central  Google Scholar 

  49. Mehta SP, Bailey D, Davies N. Comparative outcome of oesophagogastric cancer in younger patients. Ann R Coll Surg Engl. 2010;92(6):515–8 [Internet]. [cited 2020 Jul 29]. Available from. https://doi.org/10.1308/003588410X12664192075855.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Miedema BB, Easley J, Hamilton R. Young adults’ experiences with cancer: comments from patients and survivors. Can Fam Physician. 2006;52(11):1446–7 [Internet]. [cited 2020 Jul 29]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17279205.

    PubMed  Google Scholar 

  51. Foster MA, Attwood SEA. Current guidelines fail young patients with oesophagogastric cancer. Gut. 2002;51(2):296–7 [Internet]. [cited 2020 Jul 29]. Available from. https://doi.org/10.1136/gut.51.2.296-a.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Neal RD, Tharmanathan P, France B, Din NU, Cotton S, Fallon-Ferguson J, et al. Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review. Br J Cancer. 2015;112 Suppl 1(Suppl 1):S92–107 [Internet]. [cited 2020 Jul 29]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25734382.

    CAS  PubMed  Google Scholar 

  53. Rubin G, Walter F, Emery J, Neal R, Hamilton W, Wardle J. Research into practice: prompt diagnosis of cancer in primary care. Br J Gen Pract. 2014;64(625):428–30 [Internet]. [cited 2020 Jul 29]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25071057.

    PubMed  PubMed Central  Google Scholar 

  54. Chen Q, Zhuang H, Liu Y. The association between obesity factor and esophageal cancer. J Gastrointest Oncol. 2012;3(3):226–31.

    PubMed  PubMed Central  Google Scholar 

  55. Thrift AP, Shaheen NJ, Gammon MD, Bernstein L, Reid BJ, Onstad L, et al. Obesity and risk of esophageal adenocarcinoma and Barrett’s esophagus: a Mendelian randomization study. J Natl Cancer Inst. 2014;106(11):dju252.

    PubMed  PubMed Central  Google Scholar 

  56. Nimptsch K, Steffen A, Pischon T. Obesity and oesophageal cancer. Recent Results Cancer Res. 2016;208:67–80 [Internet]. [cited 2020 Jul 29]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27909902.

    CAS  PubMed  Google Scholar 

  57. Hoyo C, Cook MB, Kamangar F, Freedman ND, Whiteman DC, Bernstein L, et al. Body mass index in relation to oesophageal and oesophagogastric junction adenocarcinomas: a pooled analysis from the International BEACON Consortium. Int J Epidemiol. 2012;41(6):1706–18 [Internet]. [cited 2020 Jul 31]. Available from: https://academic.oup.com/ije/article/41/6/1706/746452.

    PubMed  PubMed Central  Google Scholar 

  58. Ong SK, Lai DTC, Wong JYY, Si-Ramlee KA, Razak LA, Kassim N, et al. Cross-sectional STEPwise Approach to Surveillance (STEPS) population survey of Noncommunicable Diseases (NCDs) and risk factors in Brunei Darussalam 2016. Asia Pac J Public Health. 2017;29:635–48.

    PubMed  Google Scholar 

  59. Zhang SS, Yang H, Luo KJ, Huang QY, Chen JY, Yang F, et al. The impact of body mass index on complication and survival in resected oesophageal cancer: a clinical-based cohort and meta-analysis. Br J Cancer. 2013;109(11):2894–903 [Internet]. [cited 2020 Jul 31]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24201750.

    CAS  PubMed  PubMed Central  Google Scholar 

  60. Dong J, Thrift AP. Alcohol, smoking and risk of oesophago-gastric cancer. Best Pract Res Clin Gastroenterol. 2017;31(5):509–17 [Internet]. [cited 2020 Aug 3]. Available from: https://www.sciencedirect.com/science/article/abs/pii/S1521691817300975.

    PubMed  Google Scholar 

  61. Gupta A, Majumder K, Arora N, Singh PP, Singh S. Obesity and mortality in patients with esophageal cancer: a systematic review and meta-analysis. J Clin Oncol. 2016;34(4_suppl):20 [Internet]. [cited 2020 Jul 31]. Available from. https://doi.org/10.1200/jco.2016.34.4_suppl.20.

    Article  Google Scholar 

  62. Creemers A, Ebbing EA, Hooijer GKJ, Stap L, Jibodh-Mulder RA, Gisbertz SS, et al. The dynamics of HER2 status in esophageal adenocarcinoma. Oncotarget. 2018;9(42):26787–99.

    PubMed  PubMed Central  Google Scholar 

  63. Bar-Sela G, Hershkovitz D, Haim N, Kaidar-Person O, Shulman K, Ben-Izhak O. The incidence and prognostic value of HER2 overexpression and cyclin D1 expression in patients with gastric or gastroesophageal junction adenocarcinoma in Israel. Oncol Lett. 2013;5(2):559–63.

    PubMed  Google Scholar 

  64. Prins MJD, Ruurda JP, van Diest PJ, van Hillegersberg R, Ten Kate FJW. The significance of the HER-2 status in esophageal adenocarcinoma for survival: an immunohistochemical and an in situ hybridization study. Ann Oncol. 2013;24(5):1290–7.

    CAS  PubMed  Google Scholar 

  65. Horie Y, Yoshio T, Aoyama K, Yoshimizu S, Horiuchi Y, Ishiyama A, et al. Diagnostic outcomes of esophageal cancer by artificial intelligence using convolutional neural networks. Gastrointest Endosc. 2019;89(1):25–32 [Internet]. [cited 2020 Jul 30]. Available from: https://www.sciencedirect.com/science/article/abs/pii/S0016510718329262.

    PubMed  Google Scholar 

  66. Akce M, Jiang R, Alese OB, Shaib WL, Wu C, Behera M, et al. Gastric squamous cell carcinoma and gastric adenosquamous carcinoma, clinical features and outcomes of rare clinical entities: a National Cancer Database (NCDB) analysis. J Gastrointest Oncol Vol 10, No 1 (Accessed February 2019) [Internet]. 2018; Available from: http://jgo.amegroups.com/article/view/25213

  67. Wagner AD, Syn NL, Moehler M, Grothe W, Yong WP, Tai B-C, et al. Chemotherapy for advanced gastric cancer. Cochrane Database Syst Rev. 2017;8(8):CD004064 [Internet]. [cited 2020 Jul 30]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28850174.

    PubMed  Google Scholar 

  68. Hamid S, Adnan W, Bachok N, Sidek S. A Descriptive Study on Oesophageal Cancer in Hospital Universiti Sains Malaysia. Asian J Med Heal Sci. 2020;3(1):44–51. [Internet]. [Cited 2020 Aug 1]. Available from: https://www.ajmhsrcmp.org/images/journal/Vol3_Issue1/SitiAzrin_AJMHS_2020_Vol3_Issue1_OriginalArticle_OesophagealCancer.pdf.

  69. Bowrey DJ, Griffin SM, Wayman J, Karat D, Hayes N, Raimes SA. Use of alarm symptoms to select dyspeptics for endoscopy causes patients with curable esophagogastric cancer to be overlooked. Surg Endosc. 2006;20(11):1725–8 [Internet]. [cited 2020 Jul 30]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17024539.

    CAS  PubMed  Google Scholar 

  70. Chen SL, Gwee KA, Lee JS, Miwa H, Suzuki H, Guo P, et al. Systematic review with meta-analysis: prompt endoscopy as the initial management strategy for uninvestigated dyspepsia in Asia. Aliment Pharmacol Ther. 2015;41(3):239–52 [Internet]. [cited 2020 Jul 30]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25429769.

    CAS  PubMed  Google Scholar 

  71. Alimoghaddam K, Jalali A, Aliabadi LS, Ghaffari F, Maheri R, Eini E, et al. The outcomes of esophageal and gastric cancer treatments in a retrospective study, single center experience. Int J Hematol Stem Cell Res. 2014;8(2):9–13.

    Google Scholar 

  72. Byrne JP, Mathers JM, Parry JM, Attwood SEA, Bancewicz J, Woodman CBJ. Site distribution of oesophagogastric cancer. J Clin Pathol. 2002;55(3):191–4.

    CAS  PubMed  PubMed Central  Google Scholar 

  73. ESMO. Greater awareness needed of stomach cancer risk in under-40S, especially in Latin America [ESMO World GI Press release]. 2019. [Internet]. [Cited 2020 Aug 3]. Available from: https://www.esmo.org/newsroom/press-office/esmo-world-congressgastrointestinal-cancerawareness-stomach-cancer-risk-latin-america.

  74. Zheng R, Zeng H, Zhang S, Chen W. Estimates of cancer incidence and mortality in China, 2013. Chin J Cancer. 2017;36(1):66 [Internet]. [cited 2020 Aug 1]. Available from: https://cancercommun.biomedcentral.com/articles/10.1186/s40880-017-0234-3.

    PubMed  PubMed Central  Google Scholar 

  75. Kuang J-J, Jiang Z-M, Chen Y-X, Ye W-P, Yang Q, Wang H-Z, et al. Smoking exposure and survival of patients with esophagus cancer: a systematic review and meta-analysis. Gastroenterol Res Pract. 2016;2016:7682387.

    PubMed  PubMed Central  Google Scholar 

  76. Abrams JA, Lee PC, Port JL, Altorki NK, Neugut AI. Cigarette smoking and risk of lung metastasis from esophageal cancer. Cancer Epidemiol Biomark Prev. 2008;17(10):2707–13 [Internet]. [cited 2020 Aug 3]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18843013.

    Google Scholar 

  77. Koo S, Awadelkarim B, Dhar A. The National Oesophagogastric Cancer Awareness Campaign: a locality outcome analysis from County Durham. Frontline Gastroenterol. 2017;8(4):290–4 [Internet]. [cited 2020 Jul 29]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29067156.

    PubMed  PubMed Central  Google Scholar 

  78. Battaglin F, Naseem M, Puccini A, Lenz H-J. Molecular biomarkers in gastro-esophageal cancer: recent developments, current trends and future directions. Cancer Cell Int. 2018;18:99 [Internet]. [cited 2020 Jul 29]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30008616.

    PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. PAPRSB Institute of Health Sciences, Universiti Brunei Darussalam, Jalan Tungku Link, Gadong, BE1410, Brunei Darussalam

    Nurul Syuhada Ishak, Hanif Abdul Rahman, Shirley H. F. Lee & Lin Naing

  2. The Brunei Cancer Centre, Pantai Jerudong Specialist Centre, Bandar Seri Begawan, Brunei

    Shir Kiong Lu

Authors
  1. Nurul Syuhada Ishak
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hanif Abdul Rahman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shirley H. F. Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Shir Kiong Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Lin Naing
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hanif Abdul Rahman.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ishak, N.S., Abdul Rahman, H., Lee, S.H.F. et al. Incidence, Survival and Prognostic Factors of Oesophagogastric Cancer. J Gastrointest Canc 53, 130–143 (2022). https://doi.org/10.1007/s12029-020-00559-w

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12029-020-00559-w

Keywords

Search

Navigation